289 related articles for article (PubMed ID: 30306414)
1. Dopaminergic influences on risk preferences of Parkinson's disease patients.
Kobayashi S; Asano K; Matsuda N; Ugawa Y
Cogn Affect Behav Neurosci; 2019 Feb; 19(1):88-97. PubMed ID: 30306414
[TBL] [Abstract][Full Text] [Related]
2. Perceptual decision-making in patients with Parkinson's disease.
Djamshidian A; O'Sullivan SS; Lawrence AD; Foltynie T; Aviles-Olmos I; Magdalinou N; Tomassini A; Warner TT; Lees AJ; Averbeck BB
J Psychopharmacol; 2014 Dec; 28(12):1149-54. PubMed ID: 25237123
[TBL] [Abstract][Full Text] [Related]
3. Dopamine and reward hypersensitivity in Parkinson's disease with impulse control disorder.
Drew DS; Muhammed K; Baig F; Kelly M; Saleh Y; Sarangmat N; Okai D; Hu M; Manohar S; Husain M
Brain; 2020 Aug; 143(8):2502-2518. PubMed ID: 32761061
[TBL] [Abstract][Full Text] [Related]
4. Impulse Control and Related Disorders in Parkinson's Disease.
Weintraub D; Claassen DO
Int Rev Neurobiol; 2017; 133():679-717. PubMed ID: 28802938
[TBL] [Abstract][Full Text] [Related]
5. Impulse Control Disorders in Parkinson's Disease are Associated with Alterations in Reward-Related Cortical Oscillations.
Carriere N; Bourriez JL; Delval A; Derambure P; Defebvre L; Dujardin K
J Parkinsons Dis; 2016 Jun; 6(3):651-66. PubMed ID: 27372215
[TBL] [Abstract][Full Text] [Related]
6. Dopaminergic influences on executive function and impulsive behaviour in impulse control disorders in Parkinson's disease.
Leroi I; Barraclough M; McKie S; Hinvest N; Evans J; Elliott R; McDonald K
J Neuropsychol; 2013 Sep; 7(2):306-25. PubMed ID: 23901888
[TBL] [Abstract][Full Text] [Related]
7. Dopamine replacement remediates risk aversion in Parkinson's disease in a value-independent manner.
Cherkasova MV; Corrow JC; Taylor A; Yeung SC; Stubbs JL; McKeown MJ; Appel-Cresswell S; Stoessl AJ; Barton JJS
Parkinsonism Relat Disord; 2019 Sep; 66():189-194. PubMed ID: 31473085
[TBL] [Abstract][Full Text] [Related]
8. Wait and you shall see: sexual delay discounting in hypersexual Parkinson's disease.
Girard R; Obeso I; Thobois S; Park SA; Vidal T; Favre E; Ulla M; Broussolle E; Krack P; Durif F; Dreher JC
Brain; 2019 Jan; 142(1):146-162. PubMed ID: 30590514
[TBL] [Abstract][Full Text] [Related]
9. Different effects of dopaminergic medication on perceptual decision-making in Parkinson's disease as a function of task difficulty and speed-accuracy instructions.
Huang YT; Georgiev D; Foltynie T; Limousin P; Speekenbrink M; Jahanshahi M
Neuropsychologia; 2015 Aug; 75():577-87. PubMed ID: 26184442
[TBL] [Abstract][Full Text] [Related]
10. Distinct effects of apathy and dopamine on effort-based decision-making in Parkinson's disease.
Le Heron C; Plant O; Manohar S; Ang YS; Jackson M; Lennox G; Hu MT; Husain M
Brain; 2018 May; 141(5):1455-1469. PubMed ID: 29672668
[TBL] [Abstract][Full Text] [Related]
11. Decisions under risk in Parkinson's disease: preserved evaluation of probability and magnitude.
Sharp ME; Viswanathan J; McKeown MJ; Appel-Cresswell S; Stoessl AJ; Barton JJ
Neuropsychologia; 2013 Nov; 51(13):2679-89. PubMed ID: 23954375
[TBL] [Abstract][Full Text] [Related]
12. Pramipexole-induced impulsivity in mildparkinsonian rats: a model of impulse control disorders in Parkinson's disease.
Jiménez-Urbieta H; Gago B; Quiroga-Varela A; Rodríguez-Chinchilla T; Merino-Galán L; Oregi A; Belloso-Iguerategui A; Delgado-Alvarado M; Navalpotro-Gómez I; Marin C; Fernagut PO; Rodríguez-Oroz MC
Neurobiol Aging; 2019 Mar; 75():126-135. PubMed ID: 30572183
[TBL] [Abstract][Full Text] [Related]
13. Disrupted salience network dynamics in Parkinson's disease patients with impulse control disorders.
Navalpotro-Gomez I; Kim J; Paz-Alonso PM; Delgado-Alvarado M; Quiroga-Varela A; Jimenez-Urbieta H; Carreiras M; Strafella AP; Rodriguez-Oroz MC
Parkinsonism Relat Disord; 2020 Jan; 70():74-81. PubMed ID: 31881521
[TBL] [Abstract][Full Text] [Related]
14. Impulse control disorders in Parkinson's disease patients with RLS: a cross sectional-study.
Marques A; Figorilli M; Pereira B; Derost P; Debilly B; Beudin P; Vidal T; Durif F; Fantini ML
Sleep Med; 2018 Aug; 48():148-154. PubMed ID: 29913341
[TBL] [Abstract][Full Text] [Related]
15. Risky decision-making and affective features of impulse control disorders in Parkinson's disease.
Martini A; Ellis SJ; Grange JA; Tamburin S; Dal Lago D; Vianello G; Edelstyn NMJ
J Neural Transm (Vienna); 2018 Feb; 125(2):131-143. PubMed ID: 29119257
[TBL] [Abstract][Full Text] [Related]
16. Proficient motor impulse control in Parkinson disease patients with impulsive and compulsive behaviors.
Claassen DO; van den Wildenberg WP; Harrison MB; van Wouwe NC; Kanoff K; Neimat JS; Wylie SA
Pharmacol Biochem Behav; 2015 Feb; 129():19-25. PubMed ID: 25459105
[TBL] [Abstract][Full Text] [Related]
17. Behavioral addictions in early-onset Parkinson disease are associated with DRD3 variants.
Castro-Martínez XH; García-Ruiz PJ; Martínez-García C; Martínez-Castrillo JC; Vela L; Mata M; Martínez-Torres I; Feliz-Feliz C; Palau F; Hoenicka J
Parkinsonism Relat Disord; 2018 Apr; 49():100-103. PubMed ID: 29361389
[TBL] [Abstract][Full Text] [Related]
18. Parkinson's disease-related disorders in the impulsive-compulsive spectrum.
Wolters ECh; van der Werf YD; van den Heuvel OA
J Neurol; 2008 Sep; 255 Suppl 5():48-56. PubMed ID: 18787882
[TBL] [Abstract][Full Text] [Related]
19. Dopamine restores cognitive motivation in Parkinson's disease.
McGuigan S; Zhou SH; Brosnan MB; Thyagarajan D; Bellgrove MA; Chong TT
Brain; 2019 Mar; 142(3):719-732. PubMed ID: 30689734
[TBL] [Abstract][Full Text] [Related]
20. Interval timing and Parkinson's disease: heterogeneity in temporal performance.
Merchant H; Luciana M; Hooper C; Majestic S; Tuite P
Exp Brain Res; 2008 Jan; 184(2):233-48. PubMed ID: 17828600
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
